A detailed history of Rafferty Asset Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 50,956 shares of UTHR stock, worth $18.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
50,956
Previous 65,443 22.14%
Holding current value
$18.3 Million
Previous $20.8 Million 12.41%
% of portfolio
0.06%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $4.51 Million - $5.27 Million
-14,487 Reduced 22.14%
50,956 $18.3 Million
Q2 2024

Aug 13, 2024

BUY
$228.26 - $319.04 $6.33 Million - $8.84 Million
27,713 Added 73.45%
65,443 $20.8 Million
Q1 2024

May 13, 2024

BUY
$210.76 - $249.51 $123,083 - $145,713
584 Added 1.57%
37,730 $8.67 Million
Q4 2023

Feb 13, 2024

SELL
$214.88 - $256.94 $510,984 - $611,003
-2,378 Reduced 6.02%
37,146 $8.17 Million
Q3 2023

Nov 13, 2023

BUY
$211.82 - $248.24 $679,942 - $796,850
3,210 Added 8.84%
39,524 $8.93 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $1.34 Million - $1.52 Million
6,523 Added 21.9%
36,314 $8.02 Million
Q1 2023

May 11, 2023

BUY
$212.99 - $276.17 $217,036 - $281,417
1,019 Added 3.54%
29,791 $6.67 Million
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $469,977 - $639,941
-2,282 Reduced 7.35%
28,772 $8 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $2.79 Million - $3.35 Million
13,707 Added 79.02%
31,054 $6.5 Million
Q2 2022

Aug 12, 2022

SELL
$174.81 - $241.14 $2.37 Million - $3.27 Million
-13,563 Reduced 43.88%
17,347 $4.09 Million
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $489,507 - $630,326
2,946 Added 10.53%
30,910 $5.55 Million
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $2.42 Million - $2.84 Million
13,146 Added 88.72%
27,964 $6.04 Million
Q3 2021

Nov 10, 2021

BUY
$179.86 - $214.88 $45,504 - $54,364
253 Added 1.74%
14,818 $2.74 Million
Q2 2021

Aug 10, 2021

SELL
$170.47 - $211.93 $1.08 Million - $1.34 Million
-6,312 Reduced 30.23%
14,565 $2.61 Million
Q1 2021

May 10, 2021

BUY
$153.94 - $174.85 $2.18 Million - $2.48 Million
14,155 Added 210.58%
20,877 $3.49 Million
Q4 2020

Feb 10, 2021

SELL
$101.87 - $151.79 $1.29 Million - $1.92 Million
-12,633 Reduced 65.27%
6,722 $1.02 Million
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $1.11 Million - $1.34 Million
11,084 Added 134.01%
19,355 $1.96 Million
Q2 2020

Aug 07, 2020

BUY
$92.74 - $125.82 $289,997 - $393,439
3,127 Added 60.79%
8,271 $1 Million
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $3.07 Million - $4.46 Million
-38,625 Reduced 88.25%
5,144 $488,000
Q4 2019

Feb 10, 2020

SELL
$78.31 - $95.34 $2.86 Million - $3.48 Million
-36,553 Reduced 45.51%
43,769 $3.86 Million
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $1.28 Million - $1.47 Million
17,126 Added 27.1%
80,322 $6.41 Million
Q2 2019

Aug 09, 2019

BUY
$76.06 - $120.81 $1.35 Million - $2.14 Million
17,735 Added 39.01%
63,196 $4.93 Million
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $4.87 Million - $5.77 Million
45,461 New
45,461 $5.34 Million
Q1 2018

May 15, 2018

SELL
$107.21 - $151.94 $2.94 Million - $4.17 Million
-27,456 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $3.26 Million - $4.15 Million
27,456
27,456 $4.06 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.